Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Yuhan Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Yuhan Chemical Inc.

    02 6Yuhan Chemical, Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-02-28

    Yuhan Corporation

    City : Ansan

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2025-02-28

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2024-01-12

    Yuhan Corporation

    City : Hwaseong

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2024-01-12

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2020-01-17

    Yuhan Corporation

    City : Ansan

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2020-01-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2018-11-01

    Yuhan Corporation

    City : Hwaseong

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2018-11-01

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-09-22

    Yuhan Corporation

    City : Ansan

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-09-22

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-12-04

    Yuhan Corporation

    City : Ansan

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-12-04

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-27

    Yuhan Corporation

    City : Ansan

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-06-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    IPPE
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    IPPE
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-11-08

    Yuhan Corporation

    City : Ansan

    State :

    Country/Area : South Korea

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2012-11-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Yuhan Corporation and get a quotation

    Yuhan Corporation is a supplier offers 25 products (APIs, Excipients or Intermediates).

    Find a price of Piperacillin Sodium bulk with DMF, CEP offered by Yuhan Corporation

    Find a price of Levofloxacin bulk with JDMF offered by Yuhan Corporation

    Find a price of Ribavirin bulk with DMF offered by Yuhan Corporation

    Find a price of Cilostazol bulk with JDMF offered by Yuhan Corporation

    Find a price of Ketoprofen bulk with JDMF offered by Yuhan Corporation

    Find a price of Rosuvastatin Calcium bulk with JDMF offered by Yuhan Corporation

    Find a price of Voglibose bulk with JDMF offered by Yuhan Corporation

    Find a price of Cefaclor bulk offered by Yuhan Corporation

    Find a price of Zidovudine bulk offered by Yuhan Corporation

    Find a price of FACILITY AND OPERATING PROCEDURES IN ANSANSHI, KYONGGI-DO, SOUTH KOREA bulk offered by Yuhan Corporation

    Find a price of Acoramidis Hydrochloride bulk offered by Yuhan Corporation

    Find a price of Atorvastatin bulk offered by Yuhan Corporation

    Find a price of Cobicistat bulk offered by Yuhan Corporation

    Find a price of Elvitegravir bulk offered by Yuhan Corporation

    Find a price of Emtricitabine bulk offered by Yuhan Corporation

    Find a price of Ezetimibe bulk offered by Yuhan Corporation

    Find a price of Lazertinib bulk offered by Yuhan Corporation

    Find a price of Ledipasvir bulk offered by Yuhan Corporation

    Find a price of Lenacapavir bulk offered by Yuhan Corporation

    Find a price of Revaprazan bulk offered by Yuhan Corporation

    Find a price of Sarpogrelate Hydrochloride bulk offered by Yuhan Corporation

    Find a price of Tazobactam Sodium bulk offered by Yuhan Corporation

    Find a price of Telmisartan bulk offered by Yuhan Corporation

    Find a price of Velpatasvir bulk offered by Yuhan Corporation

    Find a price of Voxilaprevir bulk offered by Yuhan Corporation

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.